BSECompany Update29 Jul 2026 · 29 Jul 2026, 11:38 am
Gland Pharma receives approval for Suggamadex Injection
Gland Pharma Ltd · 543245
✦ AI Summary▲ PositiveProduct Launch
Gland Pharma receives approval for Suggamadex Injection from the United States FDA and Drug Administration, and has successfully launched the product on the market.
Analysis Scores
Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release